Abstracts
Michelle O. Sodipo, Alicia K. Morgans, Erica T. Warner, Emily M. Rencsok, ... , Lorelei A. Mucci (2025). First-line therapies and subjective cognitive function trajectories among international metastatic hormone-sensitive prostate cancer survivors. American Association for Cancer Research (AACR) Annual Meeting.
Isani Singh, Bailey Vaselkiv, Emily M. Rencsok, ... , Lorelei A. Mucci (2024). Financial toxicity among patients with advanced prostate cancer in the United States. American Association for Cancer Research (AACR) Annual Meeting.
Naiyu Chen, Colleen B. McGrath, Caroline I. Ericsson, Jane B. Vaselkiv, Emily M. Rencsok, ... , Lorelei A. Mucci (2023). Marital status, living arrangement, and overall survival among individuals with advanced prostate cancer in the IRONMAN cohort. American Association for Cancer Research (AACR) Annual Meeting.
Emily M. Rencsok, Michelle Sodipo, Travis Gerke, ... , Lorelei A. Mucci (2022). Racial disparities in prostate cancer mortality rates explained by differences in dietary and lifestyle factors. American Association for Cancer Research (AACR) Annual Meeting.
Emily M. Rencsok, Daniel J. George, Philip W. Kantoff, ... , Lorelei A. Mucci (2022). First look at patient reported outcomes from IRONMAN, the international registry of men with advanced prostate cancer. American Society of Clinical Oncology (ASCO) Genitourinary Symposium.
Daniel J. George, Lorelei A. Mucci, Philip W. Kantoff, ... , Emily M. Rencsok (2022). IRONMAN: The international registry for men with advanced prostate cancer. American Society of Clinical Oncology (ASCO) Genitourinary Symposium.
Emily M. Rencsok, Latifa Bazzi, Rana McKay, ... , Lorelei A. Mucci (2020). Diversity of enrollment in prostate cancer clinical trials: Current status and future directions. AACR Science of Cancer Health Disparities in Racial/Ethnic Minorities and The Medically Underserved.
Lorelei A. Mucci, Claire Hampton Pernar, Emily M. Rencsok, ... , Kathryn M. Wilson (2020). 5-alpha reductase inhibitors (5-ARI) and prostate cancer mortality among men with regular access to screening and health care. American Society of Clinical Oncology (ASCO) Genitourinary Symposium.